<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmacytimes.com/view/collaborative-care-is-redefining-survival-in-multiple-myeloma</loc><lastmod>2026-04-03T19:44:00Z</lastmod><news:news><news:publication_date>2026-04-03T19:44:00Z</news:publication_date>
        <news:title><![CDATA[Collaborative Care Is Redefining Survival in Multiple Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/optimizing-athlete-performance-through-safe-medication-and-recovery-strategies</loc><lastmod>2026-04-03T15:31:00Z</lastmod><news:news><news:publication_date>2026-04-03T15:31:00Z</news:publication_date>
        <news:title><![CDATA[Optimizing Athlete Performance Through Safe Medication and Recovery Strategies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/retatrutide-delivers-significant-a1c-reduction-weight-loss-in-phase-3-type-2-diabetes-trial</loc><lastmod>2026-04-03T14:45:00Z</lastmod><news:news><news:publication_date>2026-04-03T14:45:00Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Delivers Significant A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-next-generation-pharmacy-operating-system-designed-for-health-systems</loc><lastmod>2026-04-03T13:36:00Z</lastmod><news:news><news:publication_date>2026-04-03T13:36:00Z</news:publication_date>
        <news:title><![CDATA[The Next Generation Pharmacy Operating System: Designed for Health Systems]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-how-nabp-is-modernizing-language-requirements-for-international-pharmacists</loc><lastmod>2026-04-03T13:30:00Z</lastmod><news:news><news:publication_date>2026-04-03T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: How NABP Is Modernizing Language Requirements for International Pharmacists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/one-visit-multiple-protections-navigating-rsv-vaccine-co-administration</loc><lastmod>2026-04-03T12:05:00Z</lastmod><news:news><news:publication_date>2026-04-03T12:05:00Z</news:publication_date>
        <news:title><![CDATA[One Visit, Multiple Protections: Navigating RSV Vaccine Co-Administration]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/from-hesitancy-to-action-leveraging-patient-engagement-to-boost-rsv-vaccination-rates</loc><lastmod>2026-04-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[From Hesitancy to Action: Leveraging Patient Engagement to Boost RSV Vaccination Rates ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/celebrating-the-unsung-heroes-the-inaugural-oncology-pharmacist-day-recognizes-vital-role-in-cancer-care</loc><lastmod>2026-04-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Celebrating the Unsung Heroes: The Inaugural Oncology Pharmacist Day Recognizes Vital Role in Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-unveils-new-media-studio</loc><lastmod>2026-04-02T19:37:49.172Z</lastmod><news:news><news:publication_date>2026-04-02T19:37:49.172Z</news:publication_date>
        <news:title><![CDATA[NCPA Unveils New Media Studio]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/circulating-tumor-dna-after-neoadjuvant-therapy-predicts-breast-cancer-recurrence</loc><lastmod>2026-04-02T18:00:00Z</lastmod><news:news><news:publication_date>2026-04-02T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Circulating Tumor DNA After Neoadjuvant Therapy Predicts Breast Cancer Recurrence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/more-than-1-in-3-adults-with-heart-disease-still-skip-the-flu-shot-and-disparities-are-driving-the-gap</loc><lastmod>2026-04-02T16:00:00Z</lastmod><news:news><news:publication_date>2026-04-02T16:00:00Z</news:publication_date>
        <news:title><![CDATA[More Than 1 in 3 Adults With Heart Disease Still Skip the Flu Shot, And Disparities Are Driving the Gap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-hidden-impact-of-pharmacy-supply-chain-disruption-on-patient-care</loc><lastmod>2026-04-02T15:07:00Z</lastmod><news:news><news:publication_date>2026-04-02T15:07:00Z</news:publication_date>
        <news:title><![CDATA[The Hidden Impact of Pharmacy Supply Chain Disruption on Patient Care  ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/sports-pharmacy-summit-expanding-the-pharmacist-s-role-in-athlete-health-and-performance</loc><lastmod>2026-04-02T15:00:00Z</lastmod><news:news><news:publication_date>2026-04-02T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Sports Pharmacy Summit: Expanding the Pharmacist’s Role in Athlete Health and Performance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/2026-dyslipidemia-guidelines-earlier-screening-and-what-s-coming-next</loc><lastmod>2026-04-02T14:15:00Z</lastmod><news:news><news:publication_date>2026-04-02T14:15:00Z</news:publication_date>
        <news:title><![CDATA[2026 Dyslipidemia Guidelines: Earlier Screening and What's Coming Next]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-how-pulse-by-nabp-is-bridging-the-gap-between-regulators-manufacturers-and-pharmacies-in-the-dscsa-era</loc><lastmod>2026-04-02T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-02T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: How Pulse by NABP Is Bridging the Gap Between Regulators, Manufacturers, and Pharmacies in the DSCSA Era]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/proteinuria-reduction-linked-to-lower-heart-failure-and-mortality-risk-in-ckd</loc><lastmod>2026-04-02T13:30:00Z</lastmod><news:news><news:publication_date>2026-04-02T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Proteinuria Reduction Linked to Lower Heart Failure and Mortality Risk in CKD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-quiet-consolidation-of-pharmacy-data</loc><lastmod>2026-04-01T19:34:15.207Z</lastmod><news:news><news:publication_date>2026-04-01T19:34:15.207Z</news:publication_date>
        <news:title><![CDATA[The Quiet Consolidation of Pharmacy Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/deucravacitinib-approval-expands-options-for-psoriasis-psoriatic-arthritis-care</loc><lastmod>2026-04-01T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Deucravacitinib Approval Expands Options for Psoriasis, Psoriatic Arthritis Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-orforglipron-first-glp-1-pill-without-time-food-or-water-restrictions</loc><lastmod>2026-04-01T17:48:15.731Z</lastmod><news:news><news:publication_date>2026-04-01T17:48:15.731Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-higher-dose-regimen-of-nusinersen-for-spinal-muscular-atrophy</loc><lastmod>2026-04-01T16:54:39.243Z</lastmod><news:news><news:publication_date>2026-04-01T16:54:39.243Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Higher-Dose Regimen of Nusinersen for Spinal Muscular Atrophy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/intermittent-fasting-yields-comparable-weight-loss-outcomes-with-standard-dieting</loc><lastmod>2026-04-01T16:45:00Z</lastmod><news:news><news:publication_date>2026-04-01T16:45:00Z</news:publication_date>
        <news:title><![CDATA[Intermittent Fasting Yields Comparable Weight Loss Outcomes With Standard Dieting]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/rethinking-clozapine-why-early-awareness-matters-in-treatment-resistant-schizophrenia</loc><lastmod>2026-04-01T16:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Rethinking Clozapine: Why Early Awareness Matters in Treatment-Resistant Schizophrenia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fluvoxamine-significantly-reduces-long-covid-fatigue-in-landmark-randomized-trial</loc><lastmod>2026-04-01T14:30:00Z</lastmod><news:news><news:publication_date>2026-04-01T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Fluvoxamine Significantly Reduces Long COVID Fatigue in Landmark Randomized Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-bugs-aren-t-on-vacation-what-pharmacists-need-to-know-about-the-evolving-infectious-disease-landscape</loc><lastmod>2026-04-01T14:28:01.517Z</lastmod><news:news><news:publication_date>2026-04-01T14:28:01.517Z</news:publication_date>
        <news:title><![CDATA[The Bugs Aren't on Vacation: What Pharmacists Need to Know About the Evolving Infectious Disease Landscape]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/otc-cases-acute-aches-and-pains</loc><lastmod>2026-04-01T14:04:54.302Z</lastmod><news:news><news:publication_date>2026-04-01T14:04:54.302Z</news:publication_date>
        <news:title><![CDATA[OTC Cases: Acute Aches and Pains ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-nabp-moves-to-modernize-fpgec-requirements-what-the-new-english-proficiency-recommendations-mean-for-pharmacy</loc><lastmod>2026-04-01T13:30:00Z</lastmod><news:news><news:publication_date>2026-04-01T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Expert: NABP Moves to Modernize FPGEC Requirements, What the New English Proficiency Recommendations Mean for Pharmacy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/heart-age-and-the-cardiovascular-disease-continuum-a-guide-for-pharmacists</loc><lastmod>2026-04-01T13:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Heart Age and the Cardiovascular Disease Continuum: A Guide for Pharmacists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cdk4-6-inhibitors-in-metastatic-breast-cancer-approvals-and-clinical-considerations</loc><lastmod>2026-04-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[CDK4/6 Inhibitors in Metastatic Breast Cancer: Approvals and Clinical Considerations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacist-led-strategies-to-improve-identification-and-uptake-of-cdk4-6-inhibitors-in-breast-cancer</loc><lastmod>2026-04-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacist-Led Strategies to Improve Identification and Uptake of CDK4/6 Inhibitors in Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/sleep-apnea-as-a-high-risk-comorbidity-in-hfpef</loc><lastmod>2026-03-31T21:32:00Z</lastmod><news:news><news:publication_date>2026-03-31T21:32:00Z</news:publication_date>
        <news:title><![CDATA[Sleep Apnea as a High-Risk Comorbidity in HFpEF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/phase-3-sentry-trial-demonstrates-significant-spleen-volume-reduction-with-selinexor-in-myelofibrosis</loc><lastmod>2026-03-31T16:22:00Z</lastmod><news:news><news:publication_date>2026-03-31T16:22:00Z</news:publication_date>
        <news:title><![CDATA[SENTRY Trial Data Demonstrate Significant Spleen Volume Reduction With Selinexor in Myelofibrosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/q-a-the-pharmacist-s-impact-optimizing-complex-regimens-in-parkinson-disease</loc><lastmod>2026-03-31T15:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Pharmacist’s Impact on Optimizing Complex Regimens in Parkinson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pulse-by-nabp-the-digital-tool-helping-pharmacists-and-regulators-identify-suspect-drugs-at-the-point-of-dispensing</loc><lastmod>2026-03-31T14:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Pulse by NABP: The Digital Tool Helping Pharmacists and Regulators Identify Suspect Drugs at the Point of Dispensing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/new-dyslipidemia-guidelines-restore-ldl-goals-and-expand-pharmacist-opportunities</loc><lastmod>2026-03-31T13:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T13:00:00Z</news:publication_date>
        <news:title><![CDATA[New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/oral-pcsk9-inhibition-and-the-coralreef-addon-trial</loc><lastmod>2026-03-31T01:46:00Z</lastmod><news:news><news:publication_date>2026-03-31T01:46:00Z</news:publication_date>
        <news:title><![CDATA[Oral PCSK9 Inhibition and the CORALreef AddOn Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha2026-pharmacists-have-a-critical-role-to-play-as-automated-insulin-delivery-moves-into-type-2-diabetes</loc><lastmod>2026-03-30T21:45:05.438Z</lastmod><news:news><news:publication_date>2026-03-30T21:45:05.438Z</news:publication_date>
        <news:title><![CDATA[APhA2026: Pharmacists Have a Critical Role to Play as Automated Insulin Delivery Moves Into Type 2 Diabetes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/an-ambulatory-care-pharmacist-s-perspective-on-individualizing-parkinson-disease-management</loc><lastmod>2026-03-30T18:25:59.264Z</lastmod><news:news><news:publication_date>2026-03-30T18:25:59.264Z</news:publication_date>
        <news:title><![CDATA[An Ambulatory Care Pharmacist’s Perspective on Individualizing Parkinson Disease Management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/new-data-reveal-oral-nlrp3-inhibitor-significantly-reduces-systemic-inflammation-in-obesity</loc><lastmod>2026-03-30T18:00:00Z</lastmod><news:news><news:publication_date>2026-03-30T18:00:00Z</news:publication_date>
        <news:title><![CDATA[New Data Reveal Oral NLRP3 Inhibitor Significantly Reduces Systemic Inflammation in Obesity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/new-oral-contender-outshines-standard-add-on-therapies-for-ldl-c</loc><lastmod>2026-03-30T16:51:00Z</lastmod><news:news><news:publication_date>2026-03-30T16:51:00Z</news:publication_date>
        <news:title><![CDATA[New Oral Contender Outshines Standard Add-on Therapies for LDL-C]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/scientists-identify-inflammatory-reprogramming-as-a-key-driver-of-relapse-in-small-cell-lung-cancer</loc><lastmod>2026-03-30T15:00:00Z</lastmod><news:news><news:publication_date>2026-03-30T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Scientists Identify Inflammatory Reprogramming as a Key Driver of Relapse in Small Cell Lung Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/-walking-with-patients-how-pharmacists-can-ease-the-emotional-and-financial-weight-of-breast-cancer-care</loc><lastmod>2026-03-30T13:44:00Z</lastmod><news:news><news:publication_date>2026-03-30T13:44:00Z</news:publication_date>
        <news:title><![CDATA[“Walking With Patients”: How Pharmacists Can Ease the Emotional and Financial Weight of Breast Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-what-is-the-toefl-ibt-requirement-for-foreign-pharmacy-graduates-and-why-is-nabp-reviewing-it-</loc><lastmod>2026-03-30T13:30:00Z</lastmod><news:news><news:publication_date>2026-03-30T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Expert: What Is the TOEFL iBT Requirement for Foreign Pharmacy Graduates—and Why Is NABP Reviewing It?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/what-hemophilia-and-sickle-cell-disease-reveal-about-the-future-of-gene-therapy-access</loc><lastmod>2026-03-30T12:52:00Z</lastmod><news:news><news:publication_date>2026-03-30T12:52:00Z</news:publication_date>
        <news:title><![CDATA[What Hemophilia and Sickle Cell Disease Reveal About the Future of Gene Therapy Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-vesalius-cv-trial-evolocumab-in-high-risk-primary-prevention</loc><lastmod>2026-03-29T22:00:00Z</lastmod><news:news><news:publication_date>2026-03-29T22:00:00Z</news:publication_date>
        <news:title><![CDATA[The VESALIUS-CV Trial: Evolocumab in High-Risk Primary Prevention ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha2026-glp-1-therapies-are-rewriting-the-rules-of-metabolic-disease</loc><lastmod>2026-03-29T21:32:46.431Z</lastmod><news:news><news:publication_date>2026-03-29T21:32:46.431Z</news:publication_date>
        <news:title><![CDATA[APhA2026: GLP-1 Therapies Are Rewriting the Rules of Metabolic Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/traditional-foods-as-medicine-research-revolutionizes-heart-failure-care-in-the-navajo-nation</loc><lastmod>2026-03-29T19:25:58.903Z</lastmod><news:news><news:publication_date>2026-03-29T19:25:58.903Z</news:publication_date>
        <news:title><![CDATA[Traditional Foods as Medicine: Research Revolutionizes Heart Failure Care in the Navajo Nation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha-community-pharmacists-are-improving-outcomes-in-cardio-kidney-metabolic-syndrome</loc><lastmod>2026-03-29T18:42:51.769Z</lastmod><news:news><news:publication_date>2026-03-29T18:42:51.769Z</news:publication_date>
        <news:title><![CDATA[APhA2026: Community Pharmacists Are Improving Outcomes in Cardio-Kidney-Metabolic Syndrome]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/long-term-cardiovascular-care-10-year-data-challenge-aspirin-s-role-in-post-stent-maintenance</loc><lastmod>2026-03-29T18:04:17.289Z</lastmod><news:news><news:publication_date>2026-03-29T18:04:17.289Z</news:publication_date>
        <news:title><![CDATA[Long-Term Cardiovascular Care: 10-Year Data Challenge Aspirin’s Role in Post-Stent Maintenance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/mavacamten-in-adolescents-with-obstructive-hcm-expert-insights-from-joseph-rossano</loc><lastmod>2026-03-29T17:36:00Z</lastmod><news:news><news:publication_date>2026-03-29T17:36:00Z</news:publication_date>
        <news:title><![CDATA[Mavacamten in Adolescents with Obstructive HCM: Expert Insights From Joseph Rossano]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/mavacamten-shows-landmark-success-in-adolescent-obstructive-hcm</loc><lastmod>2026-03-29T17:05:29.101Z</lastmod><news:news><news:publication_date>2026-03-29T17:05:29.101Z</news:publication_date>
        <news:title><![CDATA[Mavacamten Shows Landmark Success in Adolescent Obstructive HCM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ryan-tedford-shares-insights-about-sotatercept-and-findings-from-the-cadence-trial</loc><lastmod>2026-03-29T16:51:00Z</lastmod><news:news><news:publication_date>2026-03-29T16:51:00Z</news:publication_date>
        <news:title><![CDATA[Ryan Tedford Shares Insights About Sotatercept and Findings From the CADENCE Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/finerenone-in-hfmref-and-hfpef-findings-from-finearts-hf</loc><lastmod>2026-03-29T16:20:00Z</lastmod><news:news><news:publication_date>2026-03-29T16:20:00Z</news:publication_date>
        <news:title><![CDATA[Finerenone in HFmrEF and HFpEF: Findings from FINEARTS-HF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/prescription-for-the-pantry-how-home-delivered-groceries-are-transforming-heart-health-in-underserved-communities</loc><lastmod>2026-03-29T12:17:00Z</lastmod><news:news><news:publication_date>2026-03-29T12:17:00Z</news:publication_date>
        <news:title><![CDATA[Prescription for the Pantry: How Home-Delivered Groceries are Transforming Heart Health in Underserved Communities]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/hypertension-women-s-cardiovascular-health-and-the-kardinal-trial</loc><lastmod>2026-03-29T02:56:00Z</lastmod><news:news><news:publication_date>2026-03-29T02:56:00Z</news:publication_date>
        <news:title><![CDATA[Hypertension, Women's Cardiovascular Health, and the KARDINAL Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/aggressive-cholesterol-lowering-may-prevent-first-heart-attacks-in-patients-with-diabetes</loc><lastmod>2026-03-28T23:11:10.626Z</lastmod><news:news><news:publication_date>2026-03-28T23:11:10.626Z</news:publication_date>
        <news:title><![CDATA[Aggressive Cholesterol Lowering May Prevent First Heart Attacks in Patients With Diabetes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha-pharmacists-are-the-front-line-of-adult-vaccination-and-the-gap-is-still-wide-open</loc><lastmod>2026-03-28T22:50:39.062Z</lastmod><news:news><news:publication_date>2026-03-28T22:50:39.062Z</news:publication_date>
        <news:title><![CDATA[APhA: Pharmacists Are the Front Line of Adult Vaccination—and the Gap Is Still Wide Open]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/new-hypertension-drug-delivers-surprising-long-term-effects-despite-mixed-trial-results</loc><lastmod>2026-03-28T22:05:39.264Z</lastmod><news:news><news:publication_date>2026-03-28T22:05:39.264Z</news:publication_date>
        <news:title><![CDATA[New Hypertension Drug Delivers "Surprising" Long-Term Effects Despite Mixed Trial Results]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha-pharmacists-critical-in-advancing-rsv-vaccination-and-equity-amid-evolving-guidelines</loc><lastmod>2026-03-28T20:48:15.733Z</lastmod><news:news><news:publication_date>2026-03-28T20:48:15.733Z</news:publication_date>
        <news:title><![CDATA[APhA: Pharmacists Critical in Advancing RSV Vaccination and Equity Amid Evolving Guidelines]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/navigating-the-2026-cholesterol-guidelines-with-john-bucheit-pharmd</loc><lastmod>2026-03-28T20:48:00Z</lastmod><news:news><news:publication_date>2026-03-28T20:48:00Z</news:publication_date>
        <news:title><![CDATA[Navigating the 2026 Cholesterol Guidelines With John Bucheit, PharmD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-pharmacists-can-lead-the-transition-as-gene-therapy-moves-into-mainstream-care</loc><lastmod>2026-03-28T20:35:02.629Z</lastmod><news:news><news:publication_date>2026-03-28T20:35:02.629Z</news:publication_date>
        <news:title><![CDATA[How Pharmacists Can Lead the Transition as Gene Therapy Moves Into Mainstream Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/building-effective-interdisciplinary-teams-for-bispecific-t-cell-engager-implementation</loc><lastmod>2026-03-28T20:06:00Z</lastmod><news:news><news:publication_date>2026-03-28T20:06:00Z</news:publication_date>
        <news:title><![CDATA[Building Effective Interdisciplinary Teams for Bispecific T-Cell Engager Implementation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/more-than-just-a-trim-barbershop-based-program-hits-the-mark-in-preventing-high-blood-pressure-among-black-men</loc><lastmod>2026-03-28T19:29:32.277Z</lastmod><news:news><news:publication_date>2026-03-28T19:29:32.277Z</news:publication_date>
        <news:title><![CDATA[More Than Just a Trim: Barbershop-Based Program Hits the Mark in Preventing High Blood Pressure in Black Men]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-blinatumomab-s-mechanism-shapes-cytokine-release-syndrome-risk-in-all-care</loc><lastmod>2026-03-28T19:20:19.436Z</lastmod><news:news><news:publication_date>2026-03-28T19:20:19.436Z</news:publication_date>
        <news:title><![CDATA[How Blinatumomab’s Mechanism Shapes Cytokine Release Syndrome Risk in ALL Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/tirzepatide-outperforms-dulaglutide-in-slashing-major-heart-and-kidney-risks-new-surpass-cvot-data-reveal</loc><lastmod>2026-03-28T18:59:46.498Z</lastmod><news:news><news:publication_date>2026-03-28T18:59:46.498Z</news:publication_date>
        <news:title><![CDATA[Tirzepatide Outperforms Dulaglutide in Slashing Major Heart and Kidney Risks, New SURPASS-CVOT Data Reveal]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/from-farm-to-pharmacy-controversial-antiparasitics-in-cancer-care</loc><lastmod>2026-03-28T17:54:00Z</lastmod><news:news><news:publication_date>2026-03-28T17:54:00Z</news:publication_date>
        <news:title><![CDATA[From Farm to Pharmacy: Controversial Antiparasitics in Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/heart-rate-vs-quality-of-life-new-data-challenge-the-standard-approach-to-long-covid-pots</loc><lastmod>2026-03-28T17:27:46.391Z</lastmod><news:news><news:publication_date>2026-03-28T17:27:46.391Z</news:publication_date>
        <news:title><![CDATA[Heart Rate vs Quality of Life: New Data Challenge the Standard Approach to Long COVID POTS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/making-sense-of-glp-1-ras-during-cancer-care-insights-from-oncology-pharmacists</loc><lastmod>2026-03-28T15:46:00Z</lastmod><news:news><news:publication_date>2026-03-28T15:46:00Z</news:publication_date>
        <news:title><![CDATA[Making Sense of GLP-1 RAs During Cancer Care: Insights from Oncology Pharmacists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/new-frontiers-in-afib-heart-device-non-inferior-to-blood-thinners-in-stroke-prevention-wins-on-safety</loc><lastmod>2026-03-28T15:29:12.353Z</lastmod><news:news><news:publication_date>2026-03-28T15:29:12.353Z</news:publication_date>
        <news:title><![CDATA[New Frontiers in AFib: Heart Device Noninferior to Blood Thinners in Stroke Prevention, Wins on Safety]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/what-clearer-preceptor-leadership-could-mean-for-residency-training</loc><lastmod>2026-03-28T14:53:27.505Z</lastmod><news:news><news:publication_date>2026-03-28T14:53:27.505Z</news:publication_date>
        <news:title><![CDATA[What Clearer Preceptor Leadership Could Mean for Residency Training]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/when-doing-good-also-causes-harm-inside-the-ethical-crossroads-of-oncology-pharmacy</loc><lastmod>2026-03-28T14:03:00Z</lastmod><news:news><news:publication_date>2026-03-28T14:03:00Z</news:publication_date>
        <news:title><![CDATA[When Doing Good Also Causes Harm: Inside the Ethical Crossroads of Oncology Pharmacy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expanding-the-standard-of-care-dostarlimab-for-advanced-endometrial-cancer</loc><lastmod>2026-03-28T02:42:00Z</lastmod><news:news><news:publication_date>2026-03-28T02:42:00Z</news:publication_date>
        <news:title><![CDATA[Expanding the Standard of Care: Dostarlimab for Advanced Endometrial Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/seeing-the-whole-patient-kelly-gable-on-the-overlooked-realities-of-breast-cancer-care</loc><lastmod>2026-03-28T01:38:21.850Z</lastmod><news:news><news:publication_date>2026-03-28T01:38:21.850Z</news:publication_date>
        <news:title><![CDATA[Seeing the Whole Patient: Kelly Gable on the Overlooked Realities of Breast Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/apha-pharmacists-can-drive-interconnected-cardio-kidney-metabolic-care</loc><lastmod>2026-03-28T00:16:34.776Z</lastmod><news:news><news:publication_date>2026-03-28T00:16:34.776Z</news:publication_date>
        <news:title><![CDATA[APhA: Pharmacists Can Drive Interconnected Cardio-Kidney-Metabolic Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/operationalizing-btces-how-pharmacists-are-driving-access-safety-and-smarter-formulary-strategy</loc><lastmod>2026-03-27T18:47:03.562Z</lastmod><news:news><news:publication_date>2026-03-27T18:47:03.562Z</news:publication_date>
        <news:title><![CDATA[Operationalizing BTCEs: How Pharmacists Are Driving Access, Safety, and Smarter Formulary Strategy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/dexamethasone-emerges-as-a-practical-alternative-to-tocilizumab-for-low-grade-crs</loc><lastmod>2026-03-27T16:40:43.579Z</lastmod><news:news><news:publication_date>2026-03-27T16:40:43.579Z</news:publication_date>
        <news:title><![CDATA[Dexamethasone Emerges as a Practical Alternative to Tocilizumab for Low-Grade CRS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-removes-age-restriction-for-neffy-1-mg-expanding-access-to-needle-free-epinephrine</loc><lastmod>2026-03-27T16:29:00Z</lastmod><news:news><news:publication_date>2026-03-27T16:29:00Z</news:publication_date>
        <news:title><![CDATA[FDA Removes Age Restriction for neffy 1 mg, Expanding Access to Needle-Free Epinephrine]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/words-matter-a-guide-to-patient-centered-language-around-medical-misinformation</loc><lastmod>2026-03-27T16:21:00Z</lastmod><news:news><news:publication_date>2026-03-27T16:21:00Z</news:publication_date>
        <news:title><![CDATA[Words Matter: A Guide to Patient-Centered Language Around Medical Misinformation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/glp-1-receptor-agonists-in-cancer-care-oncology-pharmacists-weigh-benefits-risks-and-real-world-complexities</loc><lastmod>2026-03-27T15:34:21.929Z</lastmod><news:news><news:publication_date>2026-03-27T15:34:21.929Z</news:publication_date>
        <news:title><![CDATA[GLP-1 Receptor Agonists in Cancer Care: Oncology Pharmacists Weigh Benefits, Risks, and Real-World Complexities]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/late-season-rsv-surge-extends-risk-into-spring-challenging-seasonal-expectations-expert-says</loc><lastmod>2026-03-27T15:00:00Z</lastmod><news:news><news:publication_date>2026-03-27T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Late-Season RSV Surge Extends Risk Into Spring, Challenging Seasonal Expectations, Expert Says]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/2026-dyslipidemia-guidelines-new-biomarker-recommendations-and-non-statin-treatment-options</loc><lastmod>2026-03-27T14:15:00Z</lastmod><news:news><news:publication_date>2026-03-27T14:15:00Z</news:publication_date>
        <news:title><![CDATA[2026 Dyslipidemia Guidelines: New Biomarker Recommendations and Nonstatin Treatment Options]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/inside-the-frontlines-of-btce-care-pharmacists-on-managing-a-new-toxicity-era</loc><lastmod>2026-03-27T14:15:00Z</lastmod><news:news><news:publication_date>2026-03-27T14:15:00Z</news:publication_date>
        <news:title><![CDATA[Inside the Frontlines of BTCE Care: Pharmacists on Managing a New Toxicity Era]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-marne-cel-first-stem-cell-based-gene-therapy-for-pediatric-patients-with-lad-i</loc><lastmod>2026-03-27T14:02:17.276Z</lastmod><news:news><news:publication_date>2026-03-27T14:02:17.276Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Marne-Cel, First Stem Cell-Based Gene Therapy for Pediatric Patients With LAD-I]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/beyond-the-dispensing-counter-community-service-and-volunteerism-spur-growth</loc><lastmod>2026-03-27T13:45:00Z</lastmod><news:news><news:publication_date>2026-03-27T13:45:00Z</news:publication_date>
        <news:title><![CDATA[Beyond the Dispensing Counter: Community Service and Volunteerism Spur Growth]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/overcoming-barriers-in-steroid-refractory-iraes-a-pharmacist-s-guide</loc><lastmod>2026-03-27T13:30:00Z</lastmod><news:news><news:publication_date>2026-03-27T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Overcoming Barriers in Steroid-Refractory irAEs: A Pharmacist’s Guide]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/navigating-btk-inhibitors-in-mantle-cell-lymphoma-safety-sequencing-and-evolving-pharmacist-roles</loc><lastmod>2026-03-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-03-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Navigating BTK Inhibitors in Mantle Cell Lymphoma: Safety, Sequencing, and Evolving Pharmacist Roles]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/key-takeaways-and-clinical-implications-for-pharmacists</loc><lastmod>2026-03-27T12:15:00Z</lastmod><news:news><news:publication_date>2026-03-27T12:15:00Z</news:publication_date>
        <news:title><![CDATA[Key Takeaways and Clinical Implications for Pharmacists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-hesitancy-challenge-misinformation-mistrust-and-rsv-prevention</loc><lastmod>2026-03-27T12:05:00Z</lastmod><news:news><news:publication_date>2026-03-27T12:05:00Z</news:publication_date>
        <news:title><![CDATA[The Hesitancy Challenge: Misinformation, Mistrust, and RSV Prevention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-insulin-icodec-abae-first-once-weekly-basal-insulin-for-adults-with-t2d</loc><lastmod>2026-03-27T13:32:57.224Z</lastmod><news:news><news:publication_date>2026-03-27T12:02:36.655Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Insulin Icodec-abae, First Once-Weekly Basal Insulin for Adults With T2D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/interprofessional-collaboration-and-access-for-complex-gea-regimens</loc><lastmod>2026-03-27T12:00:00Z</lastmod><news:news><news:publication_date>2026-03-27T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Interprofessional Collaboration and Access for Complex GEA Regimens]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-intersection-between-rsv-infection-and-antibiotic-overuse</loc><lastmod>2026-03-27T12:00:00Z</lastmod><news:news><news:publication_date>2026-03-27T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Intersection Between RSV Infection and Antibiotic Overuse]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/navigating-post-progression-therapy-in-hr-positive-metastatic-breast-cancer-what-pharmacists-need-to-know-now</loc><lastmod>2026-03-26T21:06:56.985Z</lastmod><news:news><news:publication_date>2026-03-26T21:06:56.985Z</news:publication_date>
        <news:title><![CDATA[Navigating Post-Progression Therapy in HR-Positive Metastatic Breast Cancer: What Pharmacists Need to Know Now]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/updates-to-340b-and-what-pharmacists-need-to-know</loc><lastmod>2026-03-26T20:53:00Z</lastmod><news:news><news:publication_date>2026-03-26T20:53:00Z</news:publication_date>
        <news:title><![CDATA[Updates to 340B and What Pharmacists Need to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/selective-bet-inhibition-with-abbv-744-shows-early-clinical-activity-in-myelofibrosis</loc><lastmod>2026-03-26T19:24:35.103Z</lastmod><news:news><news:publication_date>2026-03-26T19:24:35.103Z</news:publication_date>
        <news:title><![CDATA[Selective BET Inhibition With ABBV-744 Shows Early Clinical Activity in Myelofibrosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-pharmacists-can-navigate-key-differences-and-toxicities-of-emerging-bispecific-antibodies-in-r-r-dlbcl</loc><lastmod>2026-03-26T18:42:16.201Z</lastmod><news:news><news:publication_date>2026-03-26T18:42:16.201Z</news:publication_date>
        <news:title><![CDATA[How Pharmacists Can Navigate Key Differences and Toxicities of Emerging Bispecific Antibodies in R/R DLBCL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacy-focus-apha-preview---dr-jam-highlights-strategies-for-rsv-prevention-in-adults</loc><lastmod>2026-03-26T18:00:00Z</lastmod><news:news><news:publication_date>2026-03-26T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacy Focus: APhA Preview - Dr. JAM Highlights Strategies for RSV Prevention in Adults]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-at-the-forefront-of-multiple-sclerosis-care-clinical-decision-making-polypharmacy-and-the-expanding-role-in-research</loc><lastmod>2026-03-26T15:30:00Z</lastmod><news:news><news:publication_date>2026-03-26T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists at the Forefront of Multiple Sclerosis Care: Clinical Decision-Making, Polypharmacy, and the Expanding Role in Research]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next-</loc><lastmod>2026-03-26T15:15:00Z</lastmod><news:news><news:publication_date>2026-03-26T15:15:00Z</news:publication_date>
        <news:title><![CDATA[FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown. What’s Next?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ptcb-2025-workforce-survey-reveals-emergence-of-expert-core-and-record-high-career-dedication-among-pharmacy-technicians</loc><lastmod>2026-03-26T14:45:14.818Z</lastmod><news:news><news:publication_date>2026-03-26T14:45:14.818Z</news:publication_date>
        <news:title><![CDATA[PTCB 2025 Workforce Survey Reveals Emergence of "Expert Core" and Record High Career Dedication Among Pharmacy Technicians]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/lyme-disease-vaccine-candidate-shows-promise-as-tick-borne-risk-persists-in-the-us</loc><lastmod>2026-03-26T14:30:00Z</lastmod><news:news><news:publication_date>2026-03-26T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Lyme Disease Vaccine Candidate Shows Promise as Tick-Borne Risk Persists in the US]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/the-tarlatamab-takeover-targeting-dll3-in-extensive-stage-small-cell-lung-cancer</loc><lastmod>2026-03-26T02:30:00Z</lastmod><news:news><news:publication_date>2026-03-26T02:30:00Z</news:publication_date>
        <news:title><![CDATA[The Tarlatamab Takeover: Targeting DLL3 in Extensive Stage Small Cell Lung Cancer ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>